Tonix Pharmaceuticals Holding C - stock earnings
TNXP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -28.0 million USD | 4.0 million USD |
| 2023Q2 | -28.4 million USD | ? USD |
| 2023Q1 | -31.2 million USD | 33.9 million USD |
| 2022Q4 | -37.3 million USD | ? USD |
| 2022Q3 | -28.4 million USD | 9.7 million USD |
| 2022Q2 | -22.9 million USD | 9.0 million USD |
| 2022Q1 | -26.4 million USD | ? USD |
| 2021Q4 | -29.6 million USD | ? USD |
| 2021Q3 | -18.5 million USD | ? USD |
| 2021Q2 | -23.6 million USD | ? USD |
| 2021Q1 | -20.7 million USD | ? USD |
| 2020Q4 | -17.0 million USD | 2.9 million USD |
| 2020Q3 | -12.0 million USD | ? USD |
| 2020Q2 | -14.2 million USD | ? USD |
| 2020Q1 | -7.3 million USD | ? USD |
| 2019Q4 | -8.7 million USD | -500 USD |
| 2019Q3 | -7.8 million USD | ? USD |
| 2019Q2 | -5.8 million USD | ? USD |
| 2019Q1 | -6.2 million USD | ? USD |
| 2018Q4 | -7.6 million USD | ? USD |
| 2018Q3 | -5.5 million USD | ? USD |
| 2018Q2 | -6.1 million USD | ? USD |
| 2018Q1 | -6.9 million USD | ? USD |
| 2017Q4 | -5.5 million USD | ? USD |
| 2017Q3 | -5.8 million USD | ? USD |
| 2017Q2 | -4.8 million USD | ? USD |
| 2017Q1 | -7.5 million USD | ? USD |
| 2016Q4 | -7.5 million USD | ? USD |
| 2016Q3 | -7.6 million USD | ? USD |
| 2016Q2 | -9.8 million USD | ? USD |
| 2016Q1 | -14.0 million USD | ? USD |
| 2015Q4 | -13.4 million USD | ? USD |
| 2015Q3 | -13.3 million USD | ? USD |
| 2015Q2 | -11.8 million USD | ? USD |
| 2015Q1 | -9.7 million USD | ? USD |
| 2014Q4 | -9.0 million USD | ? USD |
| 2014Q3 | -7.4 million USD | ? USD |
| 2014Q2 | -6.0 million USD | ? USD |
| 2014Q1 | -5.2 million USD | ? USD |
| 2013Q4 | -3.7 million USD | ? USD |
| 2013Q3 | -3.1 million USD | ? USD |
| 2013Q2 | -2.1 million USD | ? USD |
| 2013Q1 | -2.0 million USD | ? USD |
| 2012Q4 | -2.6 million USD | ? USD |
| 2012Q3 | -1.7 million USD | 1875 USD |
| 2012Q2 | -3.1 million USD | ? USD |
| 2012Q1 | -2.0 million USD | ? USD |
| 2011Q4 | -3.5 million USD | ? USD |
| 2011Q3 | -2322 USD | ? USD |
| 2011Q2 | -1516 USD | ? USD |
| 2011Q1 | -5515 USD | ? USD |
| 2010Q4 | -5815 USD | ? USD |
| 2010Q3 | -3685 USD | ? USD |
| 2010Q2 | -2402 USD | ? USD |
| 2010Q1 | -5822 USD | ? USD |
| 2009Q4 | -3482 USD | ? USD |
| 2009Q3 | -2613 USD | ? USD |
| 2009Q2 | -13908 USD | ? USD |
| 2009Q1 | -10864 USD | ? USD |
| 2008Q4 | -3148 USD | ? USD |
| 2008Q3 | -3652 USD | ? USD |
| 2008Q2 | -5289 USD | ? USD |
| 2008Q1 | -9045 USD | ? USD |
TNXP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -121.0 million USD | 4.0 million USD |
| 2022 | -115.0 million USD | ? USD |
| 2021 | -92.2 million USD | ? USD |
| 2020 | -50.4 million USD | ? USD |
| 2019 | -28.4 million USD | ? USD |
| 2018 | -26.1 million USD | ? USD |
| 2017 | -21.1 million USD | ? USD |
| 2016 | -38.8 million USD | ? USD |
| 2015 | -48.1 million USD | ? USD |
| 2014 | -27.6 million USD | ? USD |
| 2013 | -10.9 million USD | ? USD |
| 2012 | -9.4 million USD | 1875 USD |
| 2011 | -3.5 million USD | ? USD |
| 2010 | -17724 USD | ? USD |
| 2009 | -30866 USD | ? USD |
| 2008 | -21134 USD | ? USD |
TNXP
Price: $0.18
52 week price:
Earnings Per Share: -6.85 USD
P/E Ratio: -0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 943700
Ebitda: -5.8 millionMarket Capitalization: 17.5 million